Saturday, June 28, 2025

Latest:

A culturally sensitive approach for pediatricians to navigate co-sleeping conversations with families
Baylor recognizes faculty excellence in research with DeBakey Awards
What you need to know about sickle cell disease
From a terrifying diagnosis to training for a marathon: Abigail’s miracle story
Researchers uncover rare gene variants contributing to systemic sclerosis risk

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

MYCN

From The Labs

Researchers identify an Achilles’ heel in neuroblastoma

August 16, 2022 cancer treatment, FATP2, fatty acid metabolism, metabolimics, MYCN, neuroblastoma, Research

A metabolic vulnerability in neuroblastoma could be exploited to overturn these tumors’ resistance to therapy.

From The Labs

Turning the molecular clock back on halts neuroblastoma tumor growth

July 27, 2021 BMAL1, brain cancer, molecular clock, MYCN, neuroblastoma, Research, RORa

Restoring function of the molecular clock blocks tumor growth in advanced neuroblastoma and can make tumors more sensitive to conventional chemotherapy.

From the Labs: a closer look at metastatic medulloblastoma